Counterterrorism and Emerging Threats
FDA plays a critical role in protecting the United States from chemical, biological, radiological, nuclear, and emerging infectious disease threats. FDA ensures that medical countermeasures (MCMs)—including drugs, vaccines and diagnostic tests—to counter these threats are safe, effective, and secure.
Medical Countermeasures Initiative (MCMi)
Popular links
![Gavel and stethoscope representing legal preparedness for public health emergencies](https://public4.pagefreezer.com:443/content/FDA/11-05-2023T12:12/https://www.fda.gov/files/styles/medium_3/public/gavel_stethoscope_1600px_0.jpg?itok=I2zpmd1h)
MCM-related counterterrorism legislation
Federal legislation enacted to strengthen the nation’s preparedness for responding to public health emergencies involving chemical, biological, radiological, nuclear (CBRN) and emerging infectious disease threats.
![Emergency sign](https://public4.pagefreezer.com:443/content/FDA/11-05-2023T12:12/https://www.fda.gov/files/styles/medium_3/public/emergency_sign_2.jpg?itok=KyobB5i0)
Emergency Use Authorization (EUA)
The EUA authority allows FDA to help strengthen the nation’s public health protections against CBRN threats by facilitating the availability and use of MCMs needed during public health emergencies.
![Robot arm and human hand meet, with gears, representing the concept of advanced manufacturing](https://public4.pagefreezer.com:443/content/FDA/11-05-2023T12:12/https://www.fda.gov/files/styles/medium_3/public/adv-manufacturing-about2-1600x900.jpg?itok=2Xcqryob)
OCET Advanced Manufacturing
Advanced manufacturing technologies can improve drug quality, address shortages of medicines, and speed time-to-market.
![Graphic showing COVID-19 testing, test processing and an illustration of the virus.](https://public4.pagefreezer.com:443/content/FDA/11-05-2023T12:12/https://www.fda.gov/files/styles/medium_3/public/COVID%20testing%20policy_1600x900_0.png?itok=qSVw8-zg)
COVID-19
Get the latest COVID-19 response updates from FDA.
More popular content
![Transmission electron micrograph of an Ebola virus virion (image: CDC/Cynthia Goldsmith)](https://public4.pagefreezer.com:443/content/FDA/11-05-2023T12:12/https://www.fda.gov/files/styles/medium_3/public/EbolaTEM_1600px_2.jpg?itok=9soo72_A)
MCM issues
MCM-related and emergency preparedness and response topics, including Ebola, mpox, antimicrobial resistance, and more.
![Various images representing activities of the Office of Counterterrorism and Emerging Threats, including law and policy, regulatory science, professional development, and medical countermeasure development and availability](https://public4.pagefreezer.com:443/content/FDA/11-05-2023T12:12/https://www.fda.gov/files/styles/medium_3/public/ocet-banner-2020-1-9.jpg?itok=OukeCWfJ)
Office of Counterterrorism and Emerging Threats
OCET provides leadership, coordination, and oversight for FDA’s national and global health security, counterterrorism, and emerging threats portfolios.
Paragraph Header
Contact Us
Assistant Commissioner for Counterterrorism Policy, and Director, OCET